Further evidence does not support hydroxychloroquine for patients with COVID-19

ScienceDaily
May 15, 2020, 5:44 pm168 pts
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to COVID-19, finds a study from France. And a randomized clinical trial from China shows that hospitalized patients with mild to moderate persistent…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Indonesia reopens Raja Ampat nickel mine despite reef damage concerns 129

Move Solar Projects Forward: Smarter & Faster Solar Project Development — Coming Webinar 129

Return to pre-COVID routines has brought Atlanta unhealthier air 127

Forests on Indigenous lands help protect health in the Amazon 126

Hyundai wants to bring back the hot hatch, and its new EV concept nails it 120

NASA to Share Details of New Perseverance Mars Rover Finding 118

Survey across the Global South sheds new light on support for climate policies 115

Vingroup Launches Unprecedented Legal Campaign Against Online Disinformation 112

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.